Crossmark

Women’s sexual scripting in the context of universal access to antiretroviral treatment—findings from the HPTN 071 (PopART) trial in South Africa

Published Online: 2021-10-24

Published Print: 2021-12

Authors

Viljoen, Lario https://orcid.org/0000-0003-4039-6639
Hoddinott, Graeme

Malunga, Samantha

Vanqa, Nosivuyile

Mhlakwaphalwa, Tembeka

Marthinus, Arlene

Mcimeli, Khanyisa

Bond, Virginia

Seeley, Janet

Bock, Peter

Hayes, Richard

Reynolds, Lindsey

,
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (UM1-AI068619, UM1-AI068617, UM1-AI068613)

U.S. President’s Emergency Plan for AIDS Relief (UM1-AI068619, UM1-AI068617, UM1-AI068613)

International Initiative for Impact Evaluation (UM1-AI068619, UM1-AI068617, UM1-AI068613)

Bill and Melinda Gates Foundation (UM1-AI068619, UM1-AI068617, UM1-AI068613)

Medical Research Foundation (UM1-AI068619, UM1-AI068617, UM1-AI068613)

National Research Foundation (MND190610444199)
License Information

Text and Data Mining valid from 2021-10-24

Version of Record valid from 2021-10-24
More Information

Article History

Received: 11 February 2021

Accepted: 14 October 2021

First Online: 24 October 2021

Declarations

:

: The HPTN 071 (PopART) trial received ethical clearance from the London School of Hygiene and Tropical Medicine and the Stellenbosch University research ethics committee (N12/09/056; N12/11/074). All participants signed written informed consent prior to participation and ongoing consent was confirmed during follow-up discussions.

: Not applicable.

: The authors have no competing interests to declare.

Document is current